Jonathan Peacock

Jonathan Peacock is the Chairman of the Board of Directors and has served on the Board since April 2017. Mr. Peacock is a member of the Nominating & Governance Committee and served as the Chair of the Audit & Finance Committee until January 2022. Mr. Peacock currently serves on the board of directors for UCB SA, where he serves as Chair of the Audit and Finance Committee.

In the past five years, Mr. Peacock served as the Chairman of the Board and as Chief Executive Officer of Bellerophon Therapeutics, Inc. He was also a founder and Chairman of Arix Bioscience PLC and served as a director of Kite Pharma where he was the Chair of the Audit and Finance Committee. Prior to that, Mr. Peacock served as the Chief Financial Officer of Amgen Inc. and Chief Financial and Administrative Officer of the pharmaceutical division of Novartis AG.

Mr. Peacock earned an M.A. in economics from the University of St. Andrews in Scotland and is a Chartered Accountant. Mr. Peacock’s prior senior leadership experience, including as Chief Executive Officer and Chief Financial Officer, current and past experience as a board member at other companies and his expertise in finance, strategy international business transactions and mergers and acquisitions, along with his independence, make him a valuable member of the Board.